🇺🇸·Aug 25Research
NCT06172296: Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Study type: INTERVENTIONAL. Phase: PHASE3.
Publisher
C
ClinicalTrials.gov
USA
This page provides a limited summary, publisher metadata, and related coverage to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- ClinicalTrials.gov
- Region
- USA
- Scope
- Research
- Published
- August 25, 2026
- Language
- EN
Publisher context, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Study type: INTERVENTIONAL. Phase: PHASE3.
Source route
Continue on clinicaltrials.gov
Leave the platform to read the original full article on the publisher site.
Source: ClinicalTrials.gov
Scope: Research
Related coverage
More related coverage
University of Minnesota/4h ago
University of Minnesota Landscape Arboretum Glass Pumpkin Patch
University of Minnesota/4h ago
Don’t panic: Three ways to lead through AI uncertainty
University of Minnesota/4h ago
Minnesota teens are using less cannabis. Some groups are still at higher risk
University of Minnesota/4h ago